---
title: "Pre-market hot trades in US stocks: Cuprina pre-market down 8.35%; Apimeds Pharmaceuticals US pre-market down 7.78%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291389356.md"
description: "Cuprina pre-market down 8.35%; Apimeds Pharmaceuticals US pre-market down 7.78%; Eason Tech pre-market up 241.98%; Eshallgo pre-market up 110.72%; Tuanche pre-market up 99.95%"
datetime: "2026-07-01T08:56:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291389356.md)
  - [en](https://longbridge.com/en/news/291389356.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291389356.md)
generator: "portal-rs"
---

# Pre-market hot trades in US stocks: Cuprina pre-market down 8.35%; Apimeds Pharmaceuticals US pre-market down 7.78%

**Pre-market Hot Trades in US Stocks**

Cuprina, down 8.35% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Apimeds Pharmaceuticals US, down 7.78% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

**Top Gainers in Pre-market US Stocks**

Eason Tech, up 241.98% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Eshallgo, up 110.72% in pre-market. Based on recent key news:

1.  On June 30, Eshallgo announced a registered direct offering at a price of $1 per share, involving 750,000 shares of Class A common stock or pre-funded warrants. This move is expected to raise approximately $750,000 in total proceeds, significantly boosting the stock price. Source: GlobeNewswire

2.  On June 30, Eshallgo signed a securities purchase agreement with certain institutional investors to sell 750,000 shares of Class A common stock at a price of $1 per share. This news further enhances market confidence in the company's future development. Source: GlobeNewswire

3.  On June 30, Eshallgo's stock price fell after announcing the $750,000 registered direct offering, indicating mixed market reactions to the offering. Source: GlobeNewswire The technology sector has been volatile recently and requires attention.

Tuanche, up 99.95% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

### Related Stocks

- [CUPR.US](https://longbridge.com/en/quote/CUPR.US.md)
- [APUS.US](https://longbridge.com/en/quote/APUS.US.md)
- [DXF.US](https://longbridge.com/en/quote/DXF.US.md)
- [EHGO.US](https://longbridge.com/en/quote/EHGO.US.md)
- [TC.US](https://longbridge.com/en/quote/TC.US.md)

## Related News & Research

- [Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19](https://longbridge.com/en/news/296655292.md)
- [Apimeds Pharmaceuticals US gains Apitox rights in assignment from South Korea’s FreeT](https://longbridge.com/en/news/296653985.md)
- [6,156,902 Shares in Rhythm Pharmaceuticals, Inc. $RYTM Purchased by BlackRock Inc.](https://longbridge.com/en/news/296751216.md)
- [Nika Pharmaceuticals publishes video investor presentation factsheet](https://longbridge.com/en/news/296928069.md)
- [Great Lakes Advisors LLC Acquires Shares of 29,800 Supernus Pharmaceuticals, Inc. $SUPN](https://longbridge.com/en/news/296676820.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**